the correct attributes to move into clinical testing. As well as modifications in the core ligands to improve target binding properties, as is done with traditional medicinal chemistry approaches, optimization of the connector and linker groups could significantly improve dimerization constants, cell permeability, and the metabolic profile of these inhibitors. Once optimized, there are a large number of indications where these inhibitors may find clinical utility. Many hematological cancers exhibit functional deregulation of Myc through genomic amplification or translocation of the Myc gene while many solid tumors, such as colorectal and lung cancer are also reported to have aberrant function of MYC, primarily caused by genomic amplification . In addition, the Myc family member N-Myc has been shown to be amplified in neuroblastoma and lung cancer, and our dimeric inhibitors would be expected to have activity versus N-Myc as well as Myc due to the high homology between their bHLHZip domains. Indeed, recent reports describe the inhibition of N-Myc in neuroblastoma cell lines with the small molecule 10058-F4 , suggesting a similar, more potent effect may also be expected with our dimeric inhibitors. In summary we have described a novel technology platform that allows for the intracellular generation of large dimeric inhibitors from monomeric components allowing the targeting of challenging or intractable targets inside the cell, exemplified here using Myc as the biological target. This approach is readily adaptable to a wide range of targets, either using pre-existing MEDChem Express RQ-00000007 well-characterized ligands, or newly identified small molecules, that bind to proximal binding sites on their target.We believe that this robust platform can be broadly deployed to deliver potent and highly selective dimeric inhibitors against drug targets that have so far resisted more traditional approaches. Influenza virus is an 160098-96-4 enveloped virus belonging to the Orthomyxoviridae family. Waterfowls are the natural reservoir for most influenza A subtypes. Avian influenza viruses bind with high affinity to ��2,3 linked sialic acid containing receptors and with low affinity to ��2,6 linked recepto
